DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma
Authors:
- 1 May 2024
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 225, 116251
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81874071, 82072933, 82103525)
- West China Hospital, Sichuan University
- Sichuan University (2020HXFH007)
- Science and Technology Department of Sichuan Province (2023ZYD0044)
This publication has 42 references indexed in Scilit:
- DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesisCellular Oncology, 2023
- Upstream stimulatory factor 2 inhibits erastin-induced ferroptosis in pancreatic cancer through transcriptional regulation of pyruvate kinase M2Biochemical Pharmacology, 2022
- Alkannin induces cytotoxic autophagy and apoptosis by promoting ROS-mediated mitochondrial dysfunction and activation of JNK pathwayBiochemical Pharmacology, 2020
- Advances in molecular classification and precision oncology in hepatocellular carcinomaJournal of Hepatology, 2020
- Targeting Ferroptosis to Iron Out CancerCancer Cell, 2019
- ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src/FAK signaling in hepatocellular carcinomaCancer Letters, 2019
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Nuclear and cytoplasmic mRNA quantification by SYBR green based real-time RT-PCRMethods, 2006